China / New Drug Approvals List 2020
The Chinese NMPA’s drug approval list for 2020 includes a surge in approvals for locally developed drugs. A total…
The Chinese NMPA’s drug approval list for 2020 includes a surge in approvals for locally developed drugs. A total…
Regarded as one of the world’s leading regulatory bodies, Swissmedic stands alongside its equivalents in Europe,…
In 2020, the US FDA’s Center for Drug Evaluation & Research (CDER) approved 53 novel drugs, up from 48 in…
The Top 10 rare disease companies globally, ranked by worldwide orphan drug sales for 2018. Celgene takes top spot,…
The Top 15 pharma companies in the Central America & Caribbean (CENCA) region’s retail market (Rx &…
The Top 20 companies on the 2021 Access to Medicines Index ranked on governance of access, research and…
The top ten global generics and biosimilars companies according to a recent Informa Pharma Intelligence ranking for…
While many parts of the world ground to a halt as they tried to deal with the global pandemic, China had more or…
In a recent article for PharmaBoardroom, Objective Capital’s David Crean took a look at the state of US…
Following the recent news of Remegen’s massive USD 515 million IPO in November 2020, we bring you the seven…
Singapore is home to a wide range of biopharmaceutical company headquarters, many of them regional bases, and…
Singapore is far ahead of its Asia-Pacific peers in terms of GDP per person. Made with Visme Infographic Maker…